Amedisys Partners with Medalogix to Drive Home Health Innovation
August 29 2018 - 4:30PM
Amedisys, Inc. (NASDAQ: AMED), America's leading independent home
health, hospice care and personal care company, today announced it
has made a minority equity investment in Medalogix, a Nashville
based Home Health and Hospice predictive modeling and analytics
company.
“We are extremely excited about our partnership with Medalogix,”
said Paul Kusserow, President and CEO of Amedisys. “Aligning
ourselves with such an innovative and powerful predictive analytics
company will not only help to further optimize our current business
and provide even better care to our patients, but also, positions
us to succeed in new and differentiated payment models. The
Medalogix platform helps drive patient insights needed for risk
arrangements and better partnerships with Managed Care
Organizations. We look forward to working with them to innovate new
products, and helping to shape the strategic direction of the
company.”
The “shift to value” in the healthcare industry is well
underway. CMS has placed focus on the “three-part aim” to: 1)
improve individual patient care; 2) provide better health outcomes
for populations; and 3) reduce costs. With this charge, home
health, guided by technology, stands as an obvious solution,
especially as Medicare Advantage enrollment continues to rise and
payors seek to form new partnerships that allow patients to receive
care in the home and age in place.
“Our industry is in the midst of revolutionary change toward
value-based care,” said Elliott Wood, President and CEO of
Medalogix. “Healthcare providers who excel in this new world will
do so by partnering with technology companies who have an aligned
focus. We’re thrilled to partner with an innovative company like
Amedisys who shares a common mission of optimal care for each
patient. We look forward to working together to improve patient
care through new paradigms for the industry.”
Amedisys partners alongside majority investor Coliseum Capital
Management, LLC. Chris Shackelton, Chairman of the Medalogix Board
and Managing Partner of Coliseum said, “Over the course of our
four-year partnership with Medalogix, Elliott and his team have
built a technology that is at the forefront of patient focused
analytics in healthcare services. Our partnership with Amedisys, a
forward-thinking provider with an aligned vision for value-based
care, will expand our strategic capabilities as we continue to grow
the industry’s only predictive analytics platform for home
health.”
Forward-Looking Statements
When included in this press release, words like “believes,”
“belief,” “expects,” “plans,” “anticipates,” “intends,” “projects,”
“estimates,” “may,” “might,” “would,” “should” and similar
expressions are intended to identify forward-looking statements as
defined by the Private Securities Litigation Reform Act of 1995.
These forward-looking statements involve a variety of risks and
uncertainties that could cause actual results to differ materially
from those described therein. These risks and uncertainties
include, but are not limited to the following: changes in Medicare
and other medical payment levels, our ability to open care centers,
acquire additional care centers and integrate and operate these
care centers effectively, changes in or our failure to comply with
existing federal and state laws or regulations or the inability to
comply with new government regulations on a timely basis,
competition in the healthcare industry, our ability to integrate
our personal care segment into our business efficiently, changes in
the case mix of patients and payment methodologies, changes in
estimates and judgments associated with critical accounting
policies, our ability to maintain or establish new patient referral
sources, our ability to attract and retain qualified personnel,
changes in payments and covered services by federal and state
governments, future cost containment initiatives undertaken by
third-party payors, our access to financing, our ability to meet
debt service requirements and comply with covenants in debt
agreements, business disruptions due to natural disasters or acts
of terrorism, our ability to integrate, manage and keep our
information systems secure, our ability to comply with requirements
stipulated in our corporate integrity agreement and changes in law
or developments with respect to any litigation relating to the
Company, including various other matters, many of which are beyond
our control.
Because forward-looking statements are inherently subject to
risks and uncertainties, some of which cannot be predicted or
quantified, you should not rely on any forward-looking statement as
a prediction of future events. We expressly disclaim any obligation
or undertaking and we do not intend to release publicly any updates
or changes in our expectations concerning the forward-looking
statements or any changes in events, conditions or circumstances
upon which any forward-looking statement may be based, except as
required by law.
About Amedisys:Amedisys, Inc. is a leading
healthcare at home Company delivering personalized home health,
hospice and personal care. Amedisys is focused on delivering the
care that is best for our patients, whether that is home-based
personal care; recovery and rehabilitation after an operation or
injury; care focused on empowering them to manage a chronic
disease; or hospice care at the end of life. We partner with 3,000
hospitals and 59,000 physicians nationwide have chosen Amedisys as
a partner in post-acute care. Founded in 1982, headquartered in
Baton Rouge, LA with an executive office in Nashville, TN, Amedisys
is a publicly held company. With more than 17,900 employees, in 420
care centers in 34 states and the District of Columbia, Amedisys is
dedicated to delivering the highest quality of care to the
doorsteps of more than 369,000 patients in need every year. For
more information about the Company, please
visit: www.amedisys.com.
About Medalogix:Medalogix is the only data
science company focused exclusively on home health and hospice. The
company was founded in 2012 with the desire to help home health
agencies identify patients on census at-risk for unplanned
rehospitalization. Since that time, Medalogix has developed
products and services which help home health providers create
clinical programs, manage large populations more efficiently, and
drive value to strategic partnerships. Medalogix products have been
recognized by Harvard Business Review, HIMSS, Fierce Healthcare,
and Becker’s Hospital Review as innovative solutions for improving
America’s healthcare system.
For more information, please visit Medalogix at
http://medalogix.com/ or follow on Twitter at: @Medalogix.
Contact:
Kendra KimmonsVice President of Marketing &
Communications225-299-3708kendra.kimmons@amedisys.com
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Aug 2024 to Sep 2024
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Sep 2023 to Sep 2024